Overview

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Status:
Recruiting

Trial end date:
2027-03-01

Target enrollment:

Participant gender:

Summary

In this prospective active-controlled randomized trial the investigators will assess for the first time ever the different local treatments of vulvovaginal atrophy in breast cancer patients on endocrine therapy. These patients are currently inadequately treated based on ignorance of possible treatment modalities and stigmatization of vulvovaginal atrophy.

Phase:

Phase 4

Details

Lead Sponsor:

University Hospital, Ghent

Collaborator:

University Ghent

Treatments:

Dehydroepiandrosterone
Estrogens